CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Trends Reshaping the Cell and Gene Therapies

Trends Reshaping the Cell and Gene...

A Patient-Focussed Therapeutic Measure Taking Up the Healthcare Space

A Patient-Focussed Therapeutic...

A Canadian Approach to Commercializing Cell and Gene Therapies

A Canadian Approach to...

Rocket VR Health Has Got Selected For The Newchip Seed-Stage Global Accelerator Program

Rocket VR Health Has Got Selected For...

Efficacy and Safety Data by Entasis Therapeutics from Landmark Phase 3 Attack Trial

Efficacy and Safety Data by Entasis...

Multiomic Preclinical Models to Define the Mechanism of Action

Multiomic Preclinical Models to...

Developing Patient-Centric Precision Oncology Therapies: Begin With The End In Mind

Developing Patient-Centric Precision...

What the New EMA Draft

What the New EMA Draft "Guideline on...

Trends Reshaping the Cell and Gene Therapies

Trends Reshaping the Cell and Gene...

A Patient-Focussed Therapeutic Measure Taking Up the Healthcare Space

A Patient-Focussed Therapeutic...

A Canadian Approach to Commercializing Cell and Gene Therapies

A Canadian Approach to...

Rocket VR Health Has Got Selected For The Newchip Seed-Stage Global Accelerator Program

Rocket VR Health Has Got Selected For...

Efficacy and Safety Data by Entasis Therapeutics from Landmark Phase 3 Attack Trial

Efficacy and Safety Data by Entasis...

Multiomic Preclinical Models to Define the Mechanism of Action

Multiomic Preclinical Models to...

Developing Patient-Centric Precision Oncology Therapies: Begin With The End In Mind

Developing Patient-Centric Precision...

What the New EMA Draft

What the New EMA Draft "Guideline on...

Efficiency-driven Digital Therapeutics Reshaping the European Healthcare

Life Sciences Review | Friday, January 13, 2023
Tweet

Digitised therapeutics in the healthcare sector favouring intensified medical care alike the other digital health modules, yet with a piece of proven clinical evidence and real-world outcomes.                                 


FREMONT, CA: Digital solutions have almost certainly carved a niche in almost every possible arena, with therapeutics in the healthcare sector serving as a frontier. Various applications, websites, portals, and traditional ICT, which are frequently regarded as critical eye-openers in the healthcare domain, are likely to apprehend the sector's innovations for efficient addressing of the pandemic-driven medical crisis. Owing to its complex nature in the ecosystem, embracing digitised solutions in the healthcare industry considerably favours a reduced cost, improved patient care, and seamless business opportunities. As a result, digital solutions have become an essential component of health and healthcare solutions.


Digital health radically revolves around its crucial factor, digital therapeutics (DTx), which is highly evidence-based software for the efficient treatment, management, and prevention of diseases and conditions. Comparatively analogous to drugs, the approach is a mere medical treatment, often backed by clinical evidence, thereby facilitating the achievement of efficacy as the net result of the procedure. Because of the positive outcomes enabled by the module, DTx plays an important role in treatments and healthcare. Whereas, incorporating a digital therapeutics-driven solution into the healthcare business space entails distinct considerations such as the effective nurturing of innovative businesses and, as a result, creating a transparent pathway to the market. As a result, the DTx is becoming increasingly integrated into medical care pathways.


 


The medical interventions, critically referred to as "DTx," are delivered directly to patients via evidence-based and clinically evaluated software for treating, managing, and preventing a broad spectrum of diseases and disorders in the healthcare space. Furthermore, digital therapeutics rely heavily on behavioural and lifestyle changes, in addition to combining with conventional medical treatments such as drugs or radiation therapy, and are significantly improving the treatment of untreated and undertreated conditions such as diabetes, insomnia, and, in some cases, anxiety.


Varied concepts in the healthcare sector have acquired similar space to that of digital therapeutics, for instance, digital health and medicine techniques. As a crucial treatment module in the digital healthcare zone, DTx is the spearhead of the concept with its tools, upholding the value of clinically proven and real-world results. Wherein, digital medicine eliminates the need for efficient real-world outcomes, settling with critical clinical evidence accordingly.


Meanwhile, eHealth, a branch of digital healthcare, also accumulates characteristics similar to those of DTx that may radically encompass varied emerging areas like big data, advanced computing, artificial intelligence (AI), and genomics. Similarly, mHealth uses mobile and wireless technologies to achieve healthcare goals, and thus includes various DTx and other mobile-enabled technologies.


Weekly Brief

loading
TOP VENDORS
Top 10 Therapeutics Companies – 2022
TOP VENDORS
Top 10 Emerging Therapeutics Companies – 2022
TOP VENDORS
Top 10 Therapeutics Companies – 2022
TOP VENDORS
Top 10 Emerging Therapeutics Companies – 2022
> <
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue

Read Also

Hepion Pharmaceuticals to Get a Total of $ 3.2 Million in Non-Dilutive Financing

Benefits that Medical Writing Offers

Antibodies: Immunoglobulin Isotypes

Life Science Consulting Services Trends

Rani Therapeutics and Celltrion Partner to Develop Oral Monoclonal Antibodies

ProPhase Labs Acquires BE-Smart Esophageal Pre-Cancer Screening Test

The Influence of Pharmaceutical Distributors on U.S. Drug Expenditures

Tips to Improve Medical Writing

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/efficiencydriven-digital-therapeutics-reshaping-the-european-healthcare--nwid-1080.html